{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:49:16Z","timestamp":1792205356808,"version":"4.4.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004845","name":"Haramaya University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004845","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Evidence of time to culture conversion is used to predict the time of cure from the disease and the overall drug-resistant tuberculosis (TB) treatment duration. Even though evidence about sputum culture conversion is enormous in TB treatment, no study has yet been done in our areas, where cases are common. The study aimed to assess the time to sputum conversion and its predictors among drug-resistant TB patients from October 2013 to September 2021 in eastern Ethiopia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methodology<\/jats:title>\n                  <jats:p>A retrospective cohort study was conducted in eastern Ethiopia among 273 drug-resistant TB patients who were treated from October 2013 to September 2021 at Dire Dawa City and Harari regional treatment centres. The Kaplan\u2013Meier method was used to estimate the median time of sputum culture conversion. Cox proportional hazards regression was employed to detect the predictors of sputum culture conversion. An adjusted hazard ratio (aHR) with 95% confidence interval (CI) was used to determine the strength and significance of the association.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 273 drug-resistant TB patients, the sputum culture of 216 (79.12%) patients became negative in a median time of 3\u00a0months (interquartile range 2\u20137). The time to sputum culture conversion was negatively associated with underweight (aHR 0.65 [95% CI 0.49 to 0.90]) and poor adherence (aHR 0.41 [95% CI 0.24 to 0.69]). The time to sputum culture conversion was also positively associated with patients resistant to two or more drugs (aHR 1.58 [95% CI 1.07 to 2.32]) and patients receiving a short treatment regimen (aHR 2.24 [95% CI 1.10 to 2.55]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A shorter culture conversion rate was observed compared with the median time recommended by the World Health Organization. Being underweight, poor adherence to treatment, resistance to two or more drugs and receiving a short treatment regimen were found to be predictors of time to sputum culture conversion. Implementing nutrition assessment, counselling and support of drug adherence may improve sputum culture conversion.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/inthealth\/ihae059","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:15:00Z","timestamp":1727741700000},"source":"Crossref","is-referenced-by-count":4,"title":["Sputum culture conversion and its predictors among drug-resistant pulmonary tuberculosis patients in eastern Ethiopia"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3890-5203","authenticated-orcid":false,"given":"Mulugeta","family":"Gamachu","sequence":"first","affiliation":[{"name":"School of Medicine, College of Health and Medical Sciences, Haramaya University , Harar ,","place":["Ethiopia"]},{"name":"Department of Public Health, Rift Valley University , Harar ,","place":["Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemayehu","family":"Deressa","sequence":"additional","affiliation":[{"name":"School of Public Health, College of Health and Medical Sciences, Haramaya University , Harar ,","place":["Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemma Demissei","family":"Regassa","sequence":"additional","affiliation":[{"name":"School of Public Health, College of Health and Medical Sciences, Haramaya University , Harar ,","place":["Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miesso","family":"Bayu","sequence":"additional","affiliation":[{"name":"School of Medicine, College of Health and Medical Sciences, Haramaya University , Harar ,","place":["Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibsa","family":"Mussa","sequence":"additional","affiliation":[{"name":"School of Public Health, College of Health and Medical Sciences, Haramaya University , Harar ,","place":["Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fekede Asefa","family":"Kumsa","sequence":"additional","affiliation":[{"name":"School of Public Health, College of Health and Medical Sciences, Haramaya University , Harar ,","place":["Ethiopia"]},{"name":"School of Population and Public Health, University of British Columbia , Vancouver , BC,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariku","family":"Dingeta","sequence":"additional","affiliation":[{"name":"School of Public Health, College of Health and Medical Sciences, Haramaya University , Harar ,","place":["Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"2024100100145601300_bib1","volume-title":"Global tuberculosis report 2023","author":"World Health Organization","year":"2023"},{"key":"2024100100145601300_bib2","volume-title":"Definitions and reporting framework for tuberculosis \u2013 2013 revision: updated December 2014 and January 2020","author":"World Health Organization","year":"2013"},{"key":"2024100100145601300_bib3","volume-title":"Global tuberculosis report 2019","author":"World Health Organization","year":"2019"},{"key":"2024100100145601300_bib4","article-title":"National guidelines for TB, DR-TB and leprosy in Ethiopia. Sixth edition","author":"Ethiopia Ministry of Health","year":"2017"},{"key":"2024100100145601300_bib5","volume-title":"Global tuberculosis report 2020","author":"World Health Organization","year":"2020"},{"key":"2024100100145601300_bib6","doi-asserted-by":"crossref","first-page":"8429809","DOI":"10.1155\/2018\/8429809","article-title":"Assessments of antibacterial effects of aqueous-ethanolic extracts of Sida rhombifolia\u2019s aerial part","volume":"2018","author":"Debalke","year":"2018","journal-title":"ScientificWorldJournal"},{"key":"2024100100145601300_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13690-020-00448-5","article-title":"Risk factors for mortality among drug-resistant tuberculosis patients registered for drug-resistant treatment in Amhara region, Ethiopia: a historical cohort study","volume":"78","author":"Ketema","year":"2020","journal-title":"Arch Public Health"},{"issue":"Suppl 1","key":"2024100100145601300_bib8","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ijid.2021.02.107","article-title":"Global tuberculosis report 2020 \u2013 reflections on the global TB burden, treatment and prevention efforts","volume":"113","author":"Chakaya","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2024100100145601300_bib9","volume-title":"Global tuberculosis report 2017","author":"World Health Organization","year":"2017"},{"key":"2024100100145601300_bib10","first-page":"1913","article-title":"Drug-resistant tuberculosis, KwaZulu-Natal, South Africa, 2001\u20132007","volume-title":"Emerg Infect Dis","author":"Wallengren","year":"2011"},{"key":"2024100100145601300_bib11","first-page":"1026","article-title":"Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey","volume-title":"Int J Tuberc Lung Dis","author":"Menzies","year":"2014"},{"key":"2024100100145601300_bib12","article-title":"WHO consolidated guidelines on drug-resistant tuberculosis treatment","author":"World Health Organization","year":"2019"},{"key":"2024100100145601300_bib13","volume-title":"Drug-resistant tuberculosis: a survival guide for clinicians, Third Edition","author":"Curry International Tuberculosis Center, California Department of Public Health","year":"2016"},{"key":"2024100100145601300_bib14","first-page":"322","article-title":"Time to sputum culture conversion and treatment outcome among the first cohort of multidrug resistant tuberculosis patients in a high burden country","volume-title":"Indian J Tuberc","author":"Ige","year":"2018"},{"issue":"6","key":"2024100100145601300_bib15","doi-asserted-by":"crossref","first-page":"e0198080","DOI":"10.1371\/journal.pone.0198080","article-title":"Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia","volume":"13","author":"Shibabaw","year":"2018","journal-title":"PLoS One"},{"key":"2024100100145601300_bib16","first-page":"2547","article-title":"Predictors of time to sputum culture conversion among drug-resistant tuberculosis patients in Oromia Region Hospitals, Ethiopia","volume-title":"Infect Drug Resist","author":"Yohannes","year":"2020"},{"issue":"3","key":"2024100100145601300_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S2213-2600(15)00036-3","article-title":"Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies","volume":"3","author":"Kurbatova","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"4","key":"2024100100145601300_bib18","doi-asserted-by":"crossref","first-page":"e93206","DOI":"10.1371\/journal.pone.0093206","article-title":"Predictors of two months culture conversion in multidrug-resistant tuberculosis: findings from a retrospective cohort study","volume":"9","author":"Basit","year":"2014","journal-title":"PLoS One"},{"key":"2024100100145601300_bib19","first-page":"635","article-title":"The first population-based national tuberculosis prevalence survey in Ethiopia, 2010\u20132011","volume-title":"Int J Tuberc Lung Dis","author":"Kebede","year":"2014"},{"key":"2024100100145601300_bib20","volume-title":"As Ethiopia moves toward tuberculosis elimination, success requires higher investment","author":"Randall","year":"2016"},{"key":"2024100100145601300_bib21","first-page":"2547","article-title":"Predictors of time to sputum culture conversion among drug-resistant tuberculosis patients in Oromia region hospitals, Ethiopia","volume-title":"Infect Drug Resist","author":"Tekalegn","year":"2020"},{"key":"2024100100145601300_bib22","first-page":"e23649","article-title":"Time to sputum culture conversion and its predictors among patients with multidrug-resistant tuberculosis in Hangzhou, China","volume-title":"Medicine (Baltimore)","author":"Qingchun","year":"2020"},{"issue":"2","key":"2024100100145601300_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/ijcm.IJCM_152_17","article-title":"Sputum smear and culture conversion in multidrug resistance tuberculosis patients in seven districts of Central Gujarat, India: a longitudinal study","volume":"43","author":"Patel","year":"2018","journal-title":"Indian J Community Med"},{"key":"2024100100145601300_bib24","volume-title":"Guidelines for surveillance of drug resistance in tuberculosis","author":"World Health Organization","year":"2009"},{"key":"2024100100145601300_bib25","volume-title":"Guidelines for clinical and programmatic management of TB, TB\/HIV and leprosy in Ethiopia","author":"Ethiopia Ministry of Health","year":"2013"},{"issue":"4","key":"2024100100145601300_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3947\/ic.2016.48.4.317","article-title":"Association between body mass index and sputum culture conversion among South Korean patients with multidrug resistant tuberculosis in a tuberculosis referral hospital","volume":"48","author":"Park","year":"2016","journal-title":"Infect Chemother"},{"key":"2024100100145601300_bib27","first-page":"114","article-title":"Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China","volume-title":"BMC Infect Dis","author":"Liu","year":"2018"},{"issue":"6","key":"2024100100145601300_bib28","doi-asserted-by":"crossref","first-page":"e0199320","DOI":"10.1371\/journal.pone.0199320","article-title":"Time to sputum culture conversion and its determinants among multi-drug resistant tuberculosis patients at public hospitals of the Amhara Regional State: a multicenter retrospective follow up study","volume":"13","author":"Yihunie Akalu","year":"2018","journal-title":"PLoS One"},{"key":"2024100100145601300_bib29","first-page":"347","article-title":"Models for predicting time to sputum conversion among multi-drug resistant tuberculosis patients in Lagos, South-West Nigeria","volume-title":"Front Public Health","author":"Oluwatosin","year":"2018"},{"key":"2024100100145601300_bib30","first-page":"1629","article-title":"Validity of time to sputum culture conversion to predict cure in patients with multidrug-resistant tuberculosis: a retrospective single-center study","volume-title":"Am J Trop Med Hyg","author":"Javaid","year":"2018"},{"key":"2024100100145601300_bib31","first-page":"1659","article-title":"Malnutrition is associated with delayed sputum culture conversion among patients treated for MDR-TB","volume-title":"Infect Drug Resist","author":"Asnake","year":"2021"},{"key":"2024100100145601300_bib32","first-page":"230","article-title":"Time to sputum culture conversion and its associated factors among multidrug-resistant tuberculosis patients in Eastern Africa: a systematic review and meta-analysis","volume-title":"Int J Infect Dis","author":"Assemie","year":"2020"},{"key":"2024100100145601300_bib33","first-page":"564","article-title":"Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia","volume-title":"Int J Tuberc Lung Dis","author":"Putri","year":"2014"},{"key":"2024100100145601300_bib34","first-page":"248","article-title":"Factors associated with a strong response to the T-SPOT.TB in patients with extrapulmonary tuberculosis","volume-title":"Infect Chemother","author":"Lee","year":"2014"},{"key":"2024100100145601300_bib35","first-page":"113","article-title":"Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients","volume-title":"Epidemiol Infect","author":"Podewils","year":"2011"},{"issue":"9","key":"2024100100145601300_bib36","doi-asserted-by":"crossref","first-page":"e73501","DOI":"10.1371\/journal.pone.0073501","article-title":"Adherence to tuberculosis treatment, sputum smear conversion and mortality: a retrospective cohort study in 48 Rwandan clinics","volume":"8","author":"Kayigamba","year":"2017","journal-title":"PLoS One"},{"key":"2024100100145601300_bib37","first-page":"818","article-title":"Intensive phase treatment outcome and associated factors among patients treated for multi drug resistant tuberculosis in Ethiopia: a retrospective cohort study","volume-title":"BMC Infect Dis","author":"Molie","year":"2019"},{"issue":"8","key":"2024100100145601300_bib38","doi-asserted-by":"crossref","first-page":"e1001300","DOI":"10.1371\/journal.pmed.1001300","article-title":"Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients","volume":"9","author":"Ahuja","year":"2012","journal-title":"PLoS Med"},{"issue":"9.1","key":"2024100100145601300_bib39","doi-asserted-by":"crossref","first-page":"66S","DOI":"10.3855\/jidc.13757","article-title":"9\u201312 months short treatment for patients with MDR-TB increases treatment success in Kyrgyzstan","volume":"15","author":"Zhdanova","year":"2021","journal-title":"J Infect Dev Cntries"},{"key":"2024100100145601300_bib40","first-page":"2003300","article-title":"World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update","volume-title":"Eur Respir J","author":"Mirzayev","year":"2021"},{"key":"2024100100145601300_bib41","first-page":"1335","article-title":"Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis","volume-title":"Int J Tuberc Lung Dis","author":"Kurbatova","year":"2012"}],"container-title":["International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/inthealth\/advance-article-pdf\/doi\/10.1093\/inthealth\/ihae059\/59462635\/ihae059.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/inthealth\/advance-article-pdf\/doi\/10.1093\/inthealth\/ihae059\/59462635\/ihae059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:15:09Z","timestamp":1727741709000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/inthealth\/advance-article\/doi\/10.1093\/inthealth\/ihae059\/7796910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1093\/inthealth\/ihae059","relation":{},"ISSN":["1876-3413","1876-3405"],"issn-type":[{"value":"1876-3413","type":"print"},{"value":"1876-3405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"article-number":"ihae059"}}